I’m keeping an eye on this for a re-entry.
Problem is the communication from the company.
We have no idea if Balama is producing as the company only provides updates in the quarterly.
We have no idea what’s going on with the DOE. Plenty of news around about US diversifying but what is holding up the SYR loan? Do we need a capital raise for matching funds or has there been positive discussion with the US and they may waive that?
What’s the immediate plans for Vidalia?? Once commissioned will they immediately produce at capacity or not?? What’s the demand for Vidalia product in this market??
Media Reports, page-2928
-
- There are more pages in this discussion • 573 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.005(2.22%) |
Mkt cap ! $238.0M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.0¢ | 21.5¢ | $982.9K | 4.422M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 288064 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 315613 | 3 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| SYR (ASX) Chart |